Skip to content

Vitreous Surgery With Intraocular Assistance

Vitreous Surgery With Intraocular Assistance (VISIA)

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02574624
Acronym
VISIA
Enrollment
5
Registered
2015-10-14
Start date
2015-11-30
Completion date
2017-09-30
Last updated
2017-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dislocated Intraocular Lens, Rhegmatogenous Retinal Detachments, Traction Retinal Detachments

Brief summary

To Assess the Safety of Vitreous surgery with intraocular assistance (VISIA) & to identify and document with video evidence and surgeon's case report forms intraocular maneuvers that are facilitated by VISIA.

Detailed description

Standard care surgery will be done with a few novel additions to facilitate the surgical procedure. Currently 3 ports are inserted by creating holes in the sclera (white part of the eye) to enter into the posterior part of the eye. When complex dissection is needed, a fourth port will be inserted. The assistant will insert light source through the 4th port. This eliminates the need for the surgeon to hold the light in one hand. Hence allows freeing of both hands for the surgeon to use a forceps in one hand to grasp and elevate membranes and a scissors in the other to cut connections between the retina and the membranes. When membranes are particularly thick, it can be difficult to dissect with a single forceps holding up the membrane. In this situation, a 5th port will be inserted allowing the assistant to insert a light source through one and a forceps though another. The surgeon will have a forceps in one hand and a scissors in another making dissection process more efficient.

Interventions

PROCEDUREIntraocular assistance

Intraocular assistance with help of surgical assistants during vitreous surgery (VISIA) in patients who require vitreous surgeries as part of standard of care procedure for conditions like retinal detachments, dislocated intraocular lens and glaucoma patients requiring endophotocoagulation.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

All subjects must meet the following criteria to be eligible for study entry: * Signed informed consent and authorization of use and disclosure of protected health information * Age ≥18 years * Subject will have complex retinal pathology for which it is judged that surgical objectives could be facilitated by VISIA

Exclusion criteria

Subjects who meet any of the following criteria will be ineligible for study entry: • Patients with disease processes such as macular pucker and macular hole that are generally well-managed by standard two-handed vitrectomy.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is recording of adverse events directly related to VISIA and adverse events unrelated to VISIA.4 months

Secondary

MeasureTime frame
Surgeon's assessment of the benefits and risks of VISIA recorded on the surgical case report form.4 months
Assistant's assessment of the benefits and risks of VISIA recorded on the surgical case report form.4 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026